|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/381 | |
| A61P 25/16 |
| (11) | Number of the document | 1727539 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05728686.6 |
| Date of filing the European patent application | 2005-03-22 | |
| (97) | Date of publication of the European application | 2006-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/003013 |
| Date | 2005-03-22 |
| (87) | Number | WO 2005/092331 |
| Date | 2005-10-06 |
| (30) | Number | Date | Country code |
| 102004014841 | 2004-03-24 | DE |
| (72) |
SCHELLER, Dieter, DE
|
| (73) |
SCHWARZ PHARMA AG,
Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld.,
DE
|
| (54) | VERWENDUNG VON ROTIGOTIN ZUR BEHANDLUNG UND PRÄVENTION DES PARKINSON-PLUS-SYNDROMS |
| USE OF ROTIGOTINE FOR TREATING AND PREVENTING PARKINSON`S PLUS SYNDROME |